XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Note 7 - Marketable Securities
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

7. Marketable Securities

 

The amortized cost and unrealized gains, net of marketable securities as of September 30, 2021 and December 31, 2020, are as follows (in thousands):

 

  

As of September 30, 2021

  

As of December 31, 2020

 

Marketable securities:

        

Amortized cost

 $114,194  $114,531 

Unrealized gains, net

  1,134,931   592,423 

Total fair value

 $1,249,125  $706,954 

 

During the three months ended September 30, 2021 and 2020, there were net unrealized gains on marketable securities of $457.1 million and net unrealized losses on marketable securities of $76.9 million, respectively. During the nine months ended September 30, 2021 and 2020, the net unrealized gains on marketable securities were $542.5 million and $444.6 million, respectively. These net unrealized gains are included in Gain/(loss) on marketable securities, net on the Company’s Condensed Consolidated Statements of Operations. See Footnote 14 of the Company’s Condensed Consolidated Financial Statements for fair value disclosure.